Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP350882.RAymiDC_qWC0FNXxJ9ltckqeLalCWT8RQDx-LP1_apoB8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP350882.RAymiDC_qWC0FNXxJ9ltckqeLalCWT8RQDx-LP1_apoB8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP350882.RAymiDC_qWC0FNXxJ9ltckqeLalCWT8RQDx-LP1_apoB8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP350882.RAymiDC_qWC0FNXxJ9ltckqeLalCWT8RQDx-LP1_apoB8130_provenance.
- NP350882.RAymiDC_qWC0FNXxJ9ltckqeLalCWT8RQDx-LP1_apoB8130_assertion description "[Human MOB1/glyseraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA expression was significantly decreased in the tumor of lung cancer tissue (3.347 +/- 4.306) compared with normal lung tissue (4.833 +/- 4.306; P = 0.0437), although 22 of 60 lung cancer tissue samples had > 1 tumor-normal ratio of MOB1/GAPDH mRNA expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP350882.RAymiDC_qWC0FNXxJ9ltckqeLalCWT8RQDx-LP1_apoB8130_provenance.
- NP350882.RAymiDC_qWC0FNXxJ9ltckqeLalCWT8RQDx-LP1_apoB8130_assertion evidence source_evidence_literature NP350882.RAymiDC_qWC0FNXxJ9ltckqeLalCWT8RQDx-LP1_apoB8130_provenance.
- NP350882.RAymiDC_qWC0FNXxJ9ltckqeLalCWT8RQDx-LP1_apoB8130_assertion SIO_000772 17311693 NP350882.RAymiDC_qWC0FNXxJ9ltckqeLalCWT8RQDx-LP1_apoB8130_provenance.
- NP350882.RAymiDC_qWC0FNXxJ9ltckqeLalCWT8RQDx-LP1_apoB8130_assertion wasDerivedFrom befree-20140225 NP350882.RAymiDC_qWC0FNXxJ9ltckqeLalCWT8RQDx-LP1_apoB8130_provenance.
- NP350882.RAymiDC_qWC0FNXxJ9ltckqeLalCWT8RQDx-LP1_apoB8130_assertion wasGeneratedBy ECO_0000203 NP350882.RAymiDC_qWC0FNXxJ9ltckqeLalCWT8RQDx-LP1_apoB8130_provenance.
- befree-20140225 importedOn "2014-02-25" NP350882.RAymiDC_qWC0FNXxJ9ltckqeLalCWT8RQDx-LP1_apoB8130_provenance.